[
    [
        {
            "time": "",
            "original_text": "[买入评级]凯莱英(002821)年报点评：业绩增长稳健 构建药物一体化服务生态圈",
            "features": {
                "keywords": [
                    "凯莱英",
                    "年报",
                    "业绩增长",
                    "稳健",
                    "药物一体化",
                    "服务生态圈"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级]凯莱英(002821)年报点评：业绩增长稳健 构建药物一体化服务生态圈",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[推荐评级]医药生物行业2018年二季度策略报告：把握政策利好 聚焦创新和龙头",
            "features": {
                "keywords": [
                    "医药生物",
                    "行业",
                    "政策利好",
                    "创新",
                    "龙头"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[推荐评级]医药生物行业2018年二季度策略报告：把握政策利好 聚焦创新和龙头",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "[强于大市评级]生物医药行业月报：中小创优先!医药板块发动春季攻势",
            "features": {
                "keywords": [
                    "生物医药",
                    "行业",
                    "中小创",
                    "春季攻势",
                    "医药板块"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[强于大市评级]生物医药行业月报：中小创优先!医药板块发动春季攻势",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "凯莱英2017年报点评:业绩增长迅速,海内外齐头并进",
            "features": {
                "keywords": [
                    "凯莱英",
                    "2017年报",
                    "业绩增长",
                    "迅速",
                    "海内外",
                    "齐头并进"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "凯莱英2017年报点评:业绩增长迅速,海内外齐头并进",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]